Estradiol spray
Estradiol spray (Evamist) is a metered-dose transdermal estrogen sprayed daily to the inner forearm to treat moderate to severe menopausal hot flashes.
How it works
Evamist delivers a pre-measured spray dose of estradiol to the inner forearm, where it is absorbed through the skin. Like other transdermal forms, it bypasses liver first-pass metabolism. The metered spray format removes the variability of gel measurement and the adhesive skin contact of patches. Each spray delivers a consistent dose; the total dose is adjusted by the number of sprays applied. After application, the spray must dry before covering the arm with clothing — contact transfer to children or pets before drying is a labeled safety concern, as estradiol can affect others who contact the wet application site.
For people with a uterus, a progestogen must be added. Side effects are those typical of transdermal estradiol: breast tenderness and bloating at doses higher than needed, and occasionally local skin reactions at the forearm application site. The spray format tends to have minimal skin irritation compared to patches.
How to track Estradiol spray
- Hot flash frequency and severity — the primary measure of whether the daily spray dose is maintaining adequate estradiol levels.
- Number of sprays per application and application time — the dose is adjusted by spray count; consistency is essential for stable levels.
- Breast tenderness and bloating — the most common signals of dose overshoot.
- Skin reactions at the inner forearm application site — redness or irritation, though typically milder than with adhesive patches.
- Night sweats and sleep quality as secondary vasomotor response measures.
- Apply at the same time each day and log the number of sprays — inconsistent spray counts introduce dose variability that can cause unexplained symptom fluctuations.
- Note the drying time after application: covering the forearm too quickly can reduce absorption; logging any 'rushed days' helps correlate them with symptom patterns.
- Track hot flash frequency weekly for the first eight weeks, comparing to your pre-treatment baseline — transdermal dose optimization typically takes two to four weeks to stabilize.
- Log breast tenderness and bloating separately — they are the most consistent early signs that a dose is higher than the minimum effective level.
- If you have children or pets in the household, log any incidents where the application site was contacted before drying — this is a safety consideration worth noting.
Questions to ask your physician
- My pre-treatment baseline was [X] hot flashes per day. At [N] weeks using [Y sprays] of Evamist, my current weekly average is [Z]. Is that response level consistent with what's expected at this dose?
- My breast tenderness log shows [pattern] — does that suggest the current spray count is higher than the minimum effective dose?
- I've been tracking application consistency — here are the days where I may have applied unevenly or covered the area before it dried. Could those account for my symptom variability?
- My night sweat log shows [X] episodes per week at [N] weeks. Is that the expected trajectory for vasomotor response with transdermal estradiol?